1. Slapak, C. A. & Kufe, D. W. in Harrison's Principles of Internal Medicine 14th edn (eds Isselbacher, K. J. et al.) 523–537 (McGraw–Hill, Inc. (Health Professions Div., New York, 1998).
2. Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR–ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344, 1031–1037 (2001).
3. Kohn, K. Beyond DNA cross-linking: history and prospects of DNA–targeted cancer treatment. Fifteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 56, 5533–5546 (1996).
4. Infield, G. B. Disaster at Bari (Macmillan, New York, 1971).
5. Ward, K. Jr. The chlorinated ethylamines: a new type of vesicant. J. Am. Chem. Soc. 57, 914–916 (1935).